Veeva Systems

Veeva Systems provides industry cloud solutions for the life sciences industry. Veeva Commercial Cloud is a suite of multichannel customer relationship management applications, a commercial data warehouse, territory allocation and alignment applications, master data management applications and customer reference and data and services. Veeva Vault is the company's suite of cloud-based, enterprise content management applications that address the content management requirements for the company's customers'commercial functions, including medical and sales and marketing, and key research and development functions, including clinical, regulatory, quality, and, when available, safety.
  • TickerVEEV
  • ISINUS9224751084
  • ExchangeNew York Stock Exchange
  • SectorSoftware & Computer Services
  • CountryUnited States

Increased risk weighs on VEEVA SYSTEMS INC, penalising its rating down to Slightly Negative

The independent financial analyst theScreener just lowered the general evaluation of VEEVA SYSTEMS INC (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 3 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date June 11, 2021, the closing price was USD 299.21 and its target price was estimated at USD 216.40.

Valens Research

Valens Equity Insights and Inflections - 2021 05 25

Current market expectations for II-VI Incorporated (IIVI) don't comprehend the company's macro tailwinds. The company supplies the technology that allows big macro trends around 5G, the Internet of Things, and autonomous vehicles to bloom. Its tailwinds from these markets continue to take off, and in the case of autonomous vehicles, it is essential to any success at all. As booming demand accelerates in these end markets, the company's likely to see strong fundamental momentum the market isn't pricing in, both in terms of growth and profitability. Markets expect UAFRS-based ROA (Uniform...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

ullish Tape Despite Inconsistencies Despite the bulls still being in control, we have several ongoing concerns and we cannot rule out the potential for a pullback. Below we highlight developments that are inconsistent with a major bottom in equities that suggests the broad equity market is not yet out of the woods. · S&P 500 Short-Term Levels. We continue to respect the bullish tape, however the S&P 500 remains in the 2855-2900 resistance zone while forming a bearish rising wedge pattern. This pattern results in a breakdown roughly 70% of the time. Still, support at 2760 would need ...

Valens Research

Valens Equity Insights and Inflections - 2021 05 25

Current market expectations for II-VI Incorporated (IIVI) don't comprehend the company's macro tailwinds. The company supplies the technology that allows big macro trends around 5G, the Internet of Things, and autonomous vehicles to bloom. Its tailwinds from these markets continue to take off, and in the case of autonomous vehicles, it is essential to any success at all. As booming demand accelerates in these end markets, the company's likely to see strong fundamental momentum the market isn't pricing in, both in terms of growth and profitability. Markets expect UAFRS-based ROA (Uniform...

Valens Research

Valens Equity Insights and Inflections - 2020 07 07

K is currently trading near recent averages relative to Uniform earnings, with a 25.0x Uniform P/E (Fwd V/E'). At these levels, the market is pricing in expectations for Uniform ROA to expand from 14% in 2019 to a historical high of 25% in 2024, accompanied by 4% Uniform asset shrinkage going forward. Meanwhile, analysts have similar expectations, projecting Uniform ROA to improve to 17% by 2021, accompanied by 5% Uniform asset shrinkage. However, management appears concerned about their targeted brand investments, warehouse logistics, and their cereal products. Current valuations appear to be...

Valens Research

VEEV - Embedded Expectations Analysis - 2020 07 06

Veeva Systems Inc. (VEEV:USA) currently trades at a historical high relative to UAFRS-based (Uniform) earnings with an 84.4x Uniform P/E, implying bullish expectations for the firm. However, management appears concerned about Veeva Engage, their Data Cloud growth strategy, and new product launches Specifically, management may lack confidence in their ability to sustain increases in remote meetings between pharma and doctors utilizing Veeva Engage, execute their Data Cloud growth strategy, and successfully launch MyVeeva in Q4. In addition, they may be overstating the potential of their new an...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Increased risk weighs on VEEVA SYSTEMS INC, penalising its rating down to Slightly Negative

The independent financial analyst theScreener just lowered the general evaluation of VEEVA SYSTEMS INC (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 3 out of 4 possible stars. Its market behaviour, however, has slightly deteriorated and will be qualified as risky moving forward. theScreener considers that these new qualifications justify an overall rating downgrade to Slightly Negative. As of the analysis date June 11, 2021, the closing price was USD 299.21 and its target price was estimated at USD 216.40.

Ford Equity US Rating and Forecast Report

Ford Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch